Ashiq Mubarack

Stock Analyst at Citigroup

(0.87)
# 3,891
Out of 4,983 analysts
3
Total ratings
66.67%
Success rate
-18.49%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Ashiq Mubarack

Mersana Therapeutics
Aug 27, 2024
Maintains: Buy
Price Target: $150$125
Current: $7.21
Upside: +1,633.70%
Alpha Tau Medical
Dec 15, 2023
Initiates: Buy
Price Target: $8
Current: $3.86
Upside: +107.25%